July 16, 2016
1 min read
Save

ASTRO members receive fellows designation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American Society for Radiation Oncology selected 10 of its members to receive ASTRO fellows designation.

The designees will be recognized during a ceremony at the ASTRO Annual Meeting, scheduled for Sept. 25-28 in Boston.

ASTRO fellows designation honors individuals who have been active or emeritus members of ASTRO for at least 15 years, given the equivalent of 10 years of service to ASTRO, and significantly added to the field of radiation oncology in the areas of research, education, patient care or service and leadership.

The society has recognized 269 fellows since 2006.

“The individuals in this class of ASTRO fellows demonstrate both talent and commitment across multiple aspects of radiation oncology, particularly in clinical care, research, service and education,” ASTRO Chair Bruce D. Minsky, MD, FASTRO, said in a press release. “As is the case for our other fellows, the clinicians and researchers in the 2016 cohort show a clear dedication to improving patients’ lives and advancing our field, especially through service to ASTRO and its initiatives.”

This year’s 10 honorees are H. Joseph Barthold, MD, of Beth Israel Deaconess Hospital-Plymouth; Jennifer R. Bellon, MD, of Dana-Farber Cancer Institute and Harvard Medical School; Laura A. Dawson, MD, of Princess Margaret Cancer Centre and University of Toronto; Theodore L. DeWeese, MD, of Johns Hopkins University; Shalom Kalnicki, MD, of Montefiore Medical Center and Albert Einstein College of Medicine; Nancy P. Mendenhall, MD, of University of Florida; William M. Mendenhall, MD, of University of Florida; Todd Pawlicki, PhD, of University of California, San Diego; Timothy D. Solberg, PhD, of University of California, San Francisco; and John H. Suh, MD, of Cleveland Clinic.